Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00037934 · ClinicalTrials.gov registry record · Phase 2

Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient

A Phase 2 study of Stroke, sponsored by US Department of Veterans Affairs.

Completed
Registry status
Phase 2
Development phase
30
Enrollment target
1
Study location

NCT00037934: Completed Phase 2 study of Stroke, sponsored by US Department of Veterans Affairs.

NCT00037934 is a Phase 2 study of Stroke that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 30 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00037934, a Phase 2 study of Stroke, has completed, sponsored by US Department of Veterans Affairs.

COMPLETED
Registry status
Phase 2
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

We have established the feasibility and effectiveness of robot-aided rehabilitation in stroke patients using a robot for neurological rehabilitation designed and built by MIT. Results of a pilot study of 20 patients were promising and showed that robot therapy is safe, tolerated by patients and produces a significant, measurable benefit. We propose to test that the robotic upper extremity trainer is an acceptable cost effective adjunct to standard occupational therapy for patients with dysfunction of the shoulder and elbow due to hemiparetic stroke in a VA rehabilitation program.

Conditions Studied

Interventions

  • DEVICE Upper extremity robot
  • OTHER Traditional Supervised Upper Extremity Exercises

Study Locations (1)

Maryland

  • VA Maryland Health Care System, Baltimore - Baltimore

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2002-04
Est. Completion 2004-12
Phase Phase 2
US Department of Veterans Affairs

632 total trials

What the finished NCT00037934 record still lists

NCT00037934 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Upper extremity robot is the first listed.

NCT00037934 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00037934 about?

NCT00037934 is a clinical study titled "Robotic Upper-Limb Neurorehabilitation in Chronic Stroke Patient". We have established the feasibility and effectiveness of robot-aided rehabilitation in stroke patients using a robot for neurological rehabilitation designed and built by MIT. Results of a pilot study of 20 patients were promising and showed that robot therapy is safe, tolerated by patients and prod...

What is the current status of trial NCT00037934?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2002-04. Estimated completion is 2004-12.

What conditions does trial NCT00037934 study?

This clinical trial studies the following conditions: Stroke.

What interventions are being tested in trial NCT00037934?

The interventions under investigation include: Upper extremity robot (DEVICE), Traditional Supervised Upper Extremity Exercises (OTHER).

Who is sponsoring clinical trial NCT00037934?

This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00037934 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00037934's enrollment target sits among peer trials

30 301st of 454 higher than 137 of 454 other Stroke trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00037934, the US trial registry maintained by the National Library of Medicine. NCT00037934 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.